NIDDK SBIR / STTR Program
Small Business Innovation Research (SBIR)
The NIH SBIR program is intended to support innovative research, conducted by small business concerns, which has the potential for commercialization. The program is designed in a two-step fashion where applicants submit a feasibility, or Phase I, application that is peer-reviewed. Typically these applications seek up to $100,000 for 6 months of research support. Successful recipients of Phase I funds may then submit Phase II applications, for both a longer duration (usually 2 years) and a larger amount (usually up to $750,000)of support. The funds for this program are 'set-aside' and therefore do not compete with the regular research, training, or other special programs supported by the Institutes.
ALL National Institutes of Health (NIH) Small Business Innovation Research (SBIR) and Small Business Technology Transfer Research (STTR) grant applicants are REQUIRED to submit applications online to the NIH through Grants.gov (http://www.grants.gov/) using the SF424 Research and Research Related (R&R) form as of the December 1, 2005, submission date (as announced in http://grants.nih.gov/grants/guide/notice-files/NOT-OD-05-067.html).
[Top]
Small Business Technology Transfer (STTR)
The NIH STTR program
is similar to the SBIR, but requires that the small business concern
partner with a research institution to perform the project that
will lead to a commercial product.
The major differences between the Small Business Innovation Research
(SBIR) and the Small Business Technology Transfer (STTR) program
are itemized below. This list is meant to provide you with enough
information to help you decide to which program you should apply.
Consultation with program staff is always encouraged if questions
arise.
- The set-aside for the SBIR program is 2.5% of the extramural
budget; the set-aside for the STTR program is 0.15% of the extramural
budget.
- In Phase I SBIR grants, a minimum of 2/3 of the work MUST
be performed by the small business concern; in Phase I STTR
grants, a minimum of 40% of the work MUST be performed by the
small business concern AND a minimum of 30% MUST be performed
by the research institution.
- In Phase II SBIR grants, a minimum of 50% of the work MUST
be performed by the small business concern; in phase II STTR
grants, the same requirements as Phase I grants must be followed,
i.e. a minimum of 40% of the work MUST be performed by the small
business, a minimum of 30% by the research institution.
- For SBIR grants, the Principal Investigator must have his/her
primary employment with the small business concern; for STTR
grants, someone at either the small business concern or the
research institution may be the P.I.
- SBIR/STTR Application Instructions (PDF) | Forms
- Federal Financial and Business Management Systems Requirement - Sample Policies and Procedures
[Top]
SBIR/STTR Research Topics
Refer to the NIDDK Current Initiatives for SBIR and STTR initiative listings.
SBIR/STTR research topics are listed in the NIDDK section of the NIH Omnibus Solicitation (PDF).
[Top]
Additional Information
Applications
may be submitted for any of the yearly
receipt dates of April 1, August 1, and December 1.
For more information, contact your NIDDK
Program Director:
DIABETES, ENDOCRINOLOGY
AND METABOLIC DISEASES |
Diabetes Complications, Interventions and Therapies
Dr. Teresa Jones
(301) 435-2996 FAX: (301) 480-3503
Email: jonest@extra.niddk.nih.gov |
Sensors/Delivery Devices and Screening, Diagnostics and Biologic Tools
Dr. Karen Teff
(301) 594-8817 FAX: (301) 480-3503
Email: teffk@niddk.nih.gov |
Islet Transplantation and Drug Development
Dr. Guillermo Arreaza-Rubin
(301) 594-8813 FAX: (301) 480-3510
Email: arreazag@mail.nih.gov |
Diabetes Behavioral Therapy and Prevention
Dr. Sanford Garfield
(301) 594-8803 Fax: (301) 480-6271
Email: garfields@extra.niddk.nih.gov |
Gene Therapy, Metabolic Diseases,
and Cystic Fibrosis
Dr. Catherine McKeon
(301) 594-8810 Fax: (301) 480-3503
Email: mckeonc@niddk.nih.gov |
Proteomics and Metabolic Profiling
Dr. Salvatore Sechi
(301) 594-8814 Fax: (301) 480-3503
Email: sechis@niddk.nih.gov |
DIGESTIVE DISEASES AND
NUTRITION |
Christine Densmore (301) 402-8714 FAX (301) 480-8300
Email: DensmoreC@extra.niddk.nih.gov |
  |
KIDNEY, UROLOGIC
AND HEMATOLOGIC DISEASES |
Kidney
Dr. Robert A. Star
(301) 594-7717 Fax: (301) 480-3510
Email: rs301p@nih.gov |
Urology
Dr. Leroy M. Nyberg
(301) 594-7717 Fax: (301) 480-3510
Email: ln10f@nih.gov |
Hematology
Dr. David G. Badman
(301) 594-7717 Fax: (301) 480-3510
Email: db70f@nih.gov |
|
For administrative and business management questions, contact:
Mrs. Helen Ling
Grants Management Specialist
National Institute of Diabetes and Digestive and Kidney Diseases
Democracy 2, Room 732
phone: (301) 594-8857;
Fax: (301) 480-3504;
email: lingh@extra.niddk.nih.gov
|
Last Updated: 10/20/2005
[Top]
|